Who Owns Corcept Therapeutics Stock?
NASDAQ: CORTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 71.92%
- Held by insiders
- 12.34%
- Institutional holders
- 633
- Institutions 71.9%
- Insiders 12.3%
- Public and other 15.7%
Who owns Corcept Therapeutics stock?
Institutional investors own about 71.9% of Corcept Therapeutics's shares, spread across 633 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 12.34% of CORT.
The largest institutional holders are Blackrock Inc. (9.32%), Ingalls & Snyder LLC (7.01%) and Renaissance Technologies, LLC (4.43%). Together, the top 10 institutions control 43.2% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their CORT positions and 7 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CORT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 10.20M | 9.32% | -18.0% |
| Ingalls & Snyder LLC | 7.67M | 7.01% | -3.4% |
| Renaissance Technologies, LLC | 4.85M | 4.43% | -7.8% |
| Vanguard Portfolio Management LLC | 4.78M | 4.36% | -5.3% |
| Vanguard Capital Management LLC | 4.35M | 3.98% | +4.3% |
| Parallel Advisors, LLC | 3.90M | 3.57% | -1.5% |
| FMR, LLC | 3.49M | 3.19% | +4.5% |
| State Street Corporation | 3.10M | 2.84% | -5.3% |
| AQR Capital Management, LLC | 2.58M | 2.36% | +535.8% |
| Geode Capital Management, LLC | 2.34M | 2.13% | -7.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CORT
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.39M | 3.10% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.89M | 2.64% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.09M | 1.91% |
| Fidelity Contrafund | 1.53M | 1.40% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.21M | 1.10% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.10M | 1.00% |
| First TRT Exch-Trd Fd.-First TRT NYSE Arca Biotechnology Index Fd. | 985.38K | 0.90% |
| SPDR S&P MIDCAP 400 ETF TRT-State Street SPDR S&P Mid Cap 400 ETF TRT | 703.36K | 0.64% |
| VANGUARD TAX-MANAGED FUNDS-Vanguard Tax-Managed Small-Cap Fund | 615.78K | 0.56% |
| iShares Trust-iShares S&P Mid-Cap 400 Growth ETF | 549.03K | 0.50% |
Frequently asked questions
Who is the largest shareholder of Corcept Therapeutics?
Blackrock Inc. is the largest institutional shareholder of CORT, owning 9.32% of shares outstanding (10.20M shares) as of its latest 13F filing.
What percentage of Corcept Therapeutics is owned by institutions?
Institutions own about 71.9% of CORT shares and 82.0% of the public float.
How much of Corcept Therapeutics do insiders own?
Insiders, such as officers and directors, own about 12.34% of CORT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.